Point72 Hong Kong LTD Beam Therapeutics Inc. Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$23.46 - $45.07 $1.13 Million - $2.18 Million	48,325 New	48,325 $1.6 Million
Q3 2022 Nov 14, 2022	BUY	$39.79 - $70.31 $496,459 - $877,257	12,477 New	12,477 $594,000
Q2 2022 Aug 15, 2022	SELL	$29.86 - $62.36 $172,083 - $359,380	-5,763 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$53.73 - $82.16 $309,645 - $473,488	5,763 New	5,763 $330,000
Q4 2021 Feb 14, 2022	SELL	$68.02 - $99.06 $128,421 - $187,025	-1,888 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$84.37 - $133.6 $159,290 - $252,236	1,888 New	1,888 $164,000

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.